Skip to main content

Drug recalls

Drug recalls from FDA, newest first.
Agency
Risk level
Date
Sold in

3 recalls

SpecGx Oxycodone and Acetaminophen CII Tablets

Oxycodone and Acetaminophen CII Tablets may have a missing imprint on the tablets.

Moderate risk, FDA, Quality testing problem

AvKARE Rosuvastatin Tablets

Rosuvastatin Tablets, USP, 10 mg, are out of specification for dissolution.

Moderate risk, FDA, Drug dissolving problem

1 recall

MediNatura ReBoost and ClearLife Nasal Sprays

ReBoost Nasal Spray and ClearLife Allergy Nasal Spray contain yeast, mold, and microbial contamination.

High risk, FDA, Contamination

2 recalls

Alembic Fesoterodine Fumarate Extended-Release Tablets

Failed impurities/degradation specifications due to levels of 'Diester Impurity' exceeding the specification limit.

Low risk, FDA, Drug impurity

Imprimis NJOF Dexamethasone Moxifloxacin and Tri-Moxi+ Intraocular Injections

Dexamethasone Moxifloxacin intraocular injections contain particulate matter - glass like particles.

Moderate risk, FDA, Foreign object